Therapeutic Attenuation of the Epithelial Sodium Channel with a SPLUNC1-derived peptide in Airway Diseases
- 4 January 2018
- journal article
- editorial
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 314 (2) , L239-L242
Abstract
The airway surface liquid (ASL) coats the lining of the airways and allows for efficient cilial movement and therefore effective mucociliary transport. Cell surface channels regulate the hydration status of the ASL and the two critical channels in the process are the cystic fibrosis transmembrane conductance regulator (CFTR) and the amiloride-sensitive epithelial sodium channel (ENaC). In cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) there is loss of CFTR function or compromised CFTR function in chronic bronchitis, respectively. CFTR function is required for chloride and bicarbonate section, and in collaboration with ENaC, maintains the normal pH and hydration status for the ASL. Interestingly, CFTR also regulates the channel activity of ENaC and dysregulation of ENaC exacerbates the CF phenotype in CFTR-related diseases. It has also been argued that increased ENaC activity results in decreased ASL thickness and mucous stasis. Although small molecule inhibitors such as amiloride have been tested as therapeutics, the adverse side effects on the renal ENaC inhibition that results in Na+ and fluid secretion have raised concerns about their safety. Here we discuss an alternative strategy proposed by Tarran and colleagues that employs a naturally occurring peptide inhibitor of ENaC, SPLUNC1, and how this peptide could be used as a potential therapeutic.Keywords
This publication has 47 references indexed in Scilit:
- Trafficking and function of the cystic fibrosis transmembrane conductance regulator: a complex network of posttranslational modificationsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2016
- The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epitheliaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2016
- Inter-α-Inhibitor Blocks Epithelial Sodium Channel Activation and Decreases Nasal Potential Differences in ΔF508 MiceAmerican Journal of Respiratory Cell and Molecular Biology, 2014
- Characterization of Defects in Ion Transport and Tissue Development in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Knockout RatsPLOS ONE, 2014
- Enhancement of alveolar epithelial sodium channel activity with decreased cystic fibrosis transmembrane conductance regulator expression in mouse lungAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- α1-Antitrypsin Inhibits Epithelial Na+ Transport In Vitro and In VivoAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavageProceedings of the National Academy of Sciences, 2009
- Aberrant CFTR-dependent HCO-3 transport in mutations associated with cystic fibrosisNature, 2001
- The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.Journal of Clinical Investigation, 1998
- Evidence for reduced Cl‐ and increased Na+ permeability in cystic fibrosis human primary cell cultures.The Journal of Physiology, 1988